The EPiTOMISE study in Homa Bay, Kenya, has just enrolled its 100th participant. Congratulations on fine work to Sarah Korwa and her team in Homa Bay.

The study is randomizing children under 10y to one of three malaria chemoprevention regimens in order to identify better ways to prevent malaria in this high-risk group of kids.

The study is registered here: https://clinicaltrials.gov/ct2/show/NCT03178643?term=NCT03178643&rank=1